PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-May-2020 Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology Sciad Newswire
05-May-2020 Cycle Pharmaceuticals and Medherant Partner to Develop Medicines using the TEPI Patch® Technology Sciad Newswire
05-May-2020 D-Flex® a New Generation of Manual Injection Pens from Haselmeier Wins Red Dot for Outstanding Design Quality B3C newswire
05-May-2020 MagForce AG Publishes Shareholder Letter MagForce AG
05-May-2020 Polyphor publishes invitation to the Annual General Meeting 2020 Polyphor AG
05-May-2020 Rapid Nutrition to Launch New Oral Anti-Viral Therapy to combat Influenza & Common Cold Rapid Nutrition PLC
05-May-2020 RAPID NUTRITION PLC:vto Launch New Oral Anti-Viral Therapy to combat Influenza & Common Cold RAPID NUTRITION PLC
04-May-2020 STRATEC REPORTS PRELIMINARY FIGURES FOR Q1 2020, RAISES GUIDANCE FOR SALES GROWTH, AND SELLS DATA SOLUTIONS BUSINESS UNIT STRATEC SE
03-May-2020 BioMarin Extends Gene Therapy Leadership with DiNAQOR in a Preclinical Collaboration and License Agreement to Develop Gene Therapies for Rare Genetic Cardiomyopathies BioMarin Pharmaceutical Inc.
03-May-2020 Zur Rose Group: Charges in connection with mail-order of non-prescription drugs and electronic prescribing Zur Rose Group AG
02-May-2020 Coronavirus (COVID-19) Update: Daily Roundup U.S. Food and Drug Administration
01-May-2020 Halozyme Announces Janssen Receives FDA Approval Of DARZALEX FASPRO(TM) Utilizing Halozyme's ENHANZE® Technology For The Treatment Of Patients With Multiple Myeloma Halozyme Therapeutics, Inc.
01-May-2020 Alume Biosciences Completes $5.5M Series A Financing Alume Biosciences
01-May-2020 ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield ADC Therapeutics SA
01-May-2020 Zyla Life Sciences to Host Conference Call and Webcast to Discuss First Quarter 2020 Financial Results on May 15, 2020 Zyla Life Sciences
01-May-2020 Sosei Heptares Notes That Enerzair® Breezhaler® (QVM149) has been Recommended for Approval in the European Union for Treating Uncontrolled Asthma Sosei Heptares
30-Apr-2020 Invitation to MorphoSys' First Quarter 2020 Results Conference Call on May 7, 2020 (news with additional features) MorphoSys AG
30-Apr-2020 MOLOGEN AG: Resignation of all Management and Supervisory Board members MOLOGEN AG
30-Apr-2020 AEVIS VICTORIA SA - Ordinary General Meeting: all proposals approved AEVIS VICTORIA SA
30-Apr-2020 AEVIS VICTORIA SA - Ordinary General Meeting: all proposals approved AEVIS VICTORIA SA